#donanemab — Public Fediverse posts

https://www.europesays.com/ie/484075/ Price reductions needed to make groundbreaking Alzheimer’s drugs available – study #Alzheimer'sDisease #dementia #donanemab #Éire #Health #IE #Ireland #Lecanemab

‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s – National

Health Canada has approved a second drug that can slow the progression of Alzheimer’s disease. Donanemab, sold by…
#NewsBeep #News #Healthcare #alzheimers #CA #Canada #donanemab #EliLilly #Health #HealthCanada
https://www.newsbeep.com/ca/658194/

‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s

https://fed.brid.gy/r/https://globalnews.ca/news/11828976/health-canada-second-drug-alzheimers/

https://www.europesays.com/ie/428522/ Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one #Alzheimer's #Brain #dementia #donanemab #Éire #Health #HealthCare #Healthcare #IE #Ireland #Lecanemab #medicine #NationalHealthCare #pharmaceuticals

Less than 20% of people in Japan who showed interest in new medications for Alzheimer's disease went on to receive one, mainly because they were not medically eligible or they decided against it for fear of side effects. https://www.japantimes.co.jp/news/2026/04/08/japan/science-health/dementia-drugs-research/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #alzheimers #lecanemab #donanemab #health #medicine #dementia #brain

Berliner Charité
#Alzheimer mit 57 Jahren
#Donanemab #Kisunla #Demenz
https://www.badische-zeitung.de/alzheimer-mit-57-patientin-hofft-auf-neues-medikament-x1x

Sleepy Don: Let's Take An Honest, Deeper Look at Trump’s Cognitive and Physical Decline

Is Donald Trump receiving treatment for early-stage Alzheimer’s disease?

The speculation centers on two datapoints: the now-famous bruise on the back of his right hand, and news that #Trump recently received an MRI.

A viral video by a medical professional suggested that the bruise pattern and the MRI schedule mirror the monthly infusion regimen for #Kisunla (#donanemab), an #Alzheimer’s drug that requires patients to undergo regular brain imaging to monitor for ARIA, a potentially dangerous swelling or bleeding.

https://michaeldsellers.substack.com/p/sleepy-don-lets-take-an-honest-deeper

🧠 Gehirn fit halten: Steht die Alzheimerforschung an einem Wendepunkt? 🤔
Neue #Medikamente wecken Hoffnung, aber es bleiben viele Fragezeichen. Der individuelle Lebensstil hat einen großen Einfluss auf die Entstehung und Genese der Krankheit. Darüber sprechen Professor Dr. Frank Jessen und Professor Dr. Alfredo Ramírez im aktuellen Unimagazin ▶️ https://uni.koeln/NYVVR

#uniköln #unicologne #uniklinikkoeln #Alzheimerforschung #Alzheimer #Gehirn #Lebensstil #Lecanemab #Donanemab

🧠 Gehirn fit halten: Steht die Alzheimerforschung an einem Wendepunkt? 🤔
Neue #Medikamente wecken Hoffnung, aber es bleiben viele Fragezeichen. Der individuelle Lebensstil hat einen großen Einfluss auf die Entstehung und Genese der Krankheit. Darüber sprechen Professor Dr. Frank Jessen und Professor Dr. Alfredo Ramírez im aktuellen Unimagazin ▶️ https://uni.koeln/NYVVR

#uniköln #unicologne #uniklinikkoeln #Alzheimerforschung #Alzheimer #Gehirn #Lebensstil #Lecanemab #Donanemab

🧠 Gehirn fit halten: Steht die Alzheimerforschung an einem Wendepunkt? 🤔
Neue #Medikamente wecken Hoffnung, aber es bleiben viele Fragezeichen. Der individuelle Lebensstil hat einen großen Einfluss auf die Entstehung und Genese der Krankheit. Darüber sprechen Professor Dr. Frank Jessen und Professor Dr. Alfredo Ramírez im aktuellen Unimagazin ▶️ https://uni.koeln/NYVVR

#uniköln #unicologne #uniklinikkoeln #Alzheimerforschung #Alzheimer #Gehirn #Lebensstil #Lecanemab #Donanemab

🧠 Gehirn fit halten: Steht die Alzheimerforschung an einem Wendepunkt? 🤔
Neue #Medikamente wecken Hoffnung, aber es bleiben viele Fragezeichen. Der individuelle Lebensstil hat einen großen Einfluss auf die Entstehung und Genese der Krankheit. Darüber sprechen Professor Dr. Frank Jessen und Professor Dr. Alfredo Ramírez im aktuellen Unimagazin ▶️ https://uni.koeln/NYVVR

#uniköln #unicologne #uniklinikkoeln #Alzheimerforschung #Alzheimer #Gehirn #Lebensstil #Lecanemab #Donanemab

🧠 Gehirn fit halten: Steht die Alzheimerforschung an einem Wendepunkt? 🤔
Neue #Medikamente wecken Hoffnung, aber es bleiben viele Fragezeichen. Der individuelle Lebensstil hat einen großen Einfluss auf die Entstehung und Genese der Krankheit. Darüber sprechen Professor Dr. Frank Jessen und Professor Dr. Alfredo Ramírez im aktuellen Unimagazin ▶️ https://uni.koeln/NYVVR

#uniköln #unicologne #uniklinikkoeln #Alzheimerforschung #Alzheimer #Gehirn #Lebensstil #Lecanemab #Donanemab

In fast-aging Japan, struggles with dementia are a common story. But researchers hope that future breakthroughs will help them rewrite the ending. https://www.japantimes.co.jp/news/2025/09/17/japan/science-health/dementia-research/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #aging #elderly #mentalhealth #alzheimer039s #medicine #pharmaceuticals #dementia #lecanemab #donanemab

FDA Approves Label Change for Alzheimer’s Drug

Brain edema risk expected to be less with new donanemab dosing schedule

The real question is whether it works?

https://cnmri.com/2025/07/14/fda-approves-label-change-for-alzheimers-drug/

#alzheimers #dementia #kisunla #donanemab #fda #brainedema

Schwellungen und Blutungen des Gehirns sind unerwünschte Wirkungen der Antikörper gegen #Alzheimer-#Demenz – und das bei eher geringem Nutzen. Dabei scheint die Bilanz für #Donanemab schlechter zu sein als bei #Lecanemab. (€)
https://gutepillen-schlechtepillen.de/antikoerper-gegen-alzheimer-wenig-nutzen-schwere-risiken/

Will this be the death knell for Alzheimer’s monoclonal antibody treatments 🤔

Preprint on #Alzheimers drug deaths ignites dispute among authors

“Infighting among a group of prominent Alzheimer’s disease researchers has led to the withdrawal of a preprint they co-authored, which suggested a new Alzheimer’s drug markedly increases the risk of death. One scientist involved in the work charges the senior author failed to seek the go-ahead from his co-authors before posting an edited version of the article to a preprint server.”

#Lecanemab #Donanemab #Kisunla #amyloid #dementia
https://www.science.org/content/article/preprint-alzheimer-s-drug-deaths-ignites-dispute-among-authors

Japan's Central Social Insurance Medical Council, which advises the health minister, approved public health insurance coverage for donanemab, an Alzheimer's medicine developed by U.S. drugmaker Eli Lilly. https://www.japantimes.co.jp/news/2024/11/13/japan/science-health/insuarance-coverage-alzheimers-drug/ #japan #sciencehealth #alzheimer039s #pharmaceuticals #donanemab #nationalhealthcare #mentalhealth #dementia #medicine

NICE rejects #Alzheimer’s drug #donanemab owing to cost and “significant health risks” | The BMJ

#Medicine #Dementia #Medications #Geriatrics #Neurology #Drugs
https://www.bmj.com/content/387/bmj.q2342?utm_source=etoc&utm_medium=email&utm_campaign=tbmj&utm_content=weekly&utm_term=20241101&uaa_id=bcc8c22efde10b08ab8a0ae8cb17af0c5c3cfc1dae30ae4bcab329dfe2dc911a&utm_campaign=This%20week%20in%20The%20BMJ&utm_medium=email&utm_source=adestra

2/2
The United States, Israel, and several Asian countries have approved #Leqembi, but on 26 July the European Medicines Agency announced its benefit in clinical trials was small and does not counterbalance the risk of serious harm. The decision comes weeks after the U.S. Food and Drug Administration approved a second antiamyloid antibody with a similar profile, #donanemab, and as Leqembi’s popularity is growing in the United States.

Science, 2 August 2024

#Alzheimer

Another very expensive drug for Alzheimer’s disease, with lots of side effects and unclear benefit

FDA OKs Another Drug for Early #Alzheimer's Disease

The FDA approved #donanemab (#Kisunla) for the treatment of adults with early symptomatic #Alzheimers disease with confirmed amyloid pathology, the agency announcedopens in a new tab or window Tuesday. This includes Alzheimer's patients with mild cognitive impairment and mild #dementia.

The once-monthly treatment is the only anti-amyloid agent with evidence to support stopping therapy when amyloid plaques

https://www.medpagetoday.com/neurology/alzheimersdisease/110934

Japan's health ministry is expected to soon approve new Alzheimer’s drug donanemab after a ministry panel backed the move. https://www.japantimes.co.jp/news/2024/08/02/japan/science-health/alzheimers-donanemab-approval-expected/ #japan #sciencehealth #elililly #alzheimer039s #pharmaceuticals #health #mentalhealth #dementia #medicine #donanemab

Will Klotho Prevent or Slow Dementia?

Klotho: Hope For Increased Longevity And Reduced Neurodegenerative Disease

“Renewed interest in a protein called klotho is pervading the scientific world. Klotho is a known anti-inflammatory protein that also contains anti-aging properties. In this two-part series, we will explore what klotho is, how it might impact inflammatory brain diseases, and how it ultimately prevents aging.”

#alzheimers #dementia #longevity #klotho #lecanemab #donanemab #aging
https://www.forbes.com/sites/williamhaseltine/2023/02/20/klotho-hope-for-increased-longevity-and-reduced-neurodegenerative-disease-part-1/

Will Klotho Prevent or Slow Dementia?

Klotho: Hope For Increased Longevity And Reduced Neurodegenerative Disease

“Renewed interest in a protein called klotho is pervading the scientific world. Klotho is a known anti-inflammatory protein that also contains anti-aging properties. In this two-part series, we will explore what klotho is, how it might impact inflammatory brain diseases, and how it ultimately prevents aging.”

#alzheimers #dementia #longevity #klotho #lecanemab #donanemab #aging
https://www.forbes.com/sites/williamhaseltine/2023/02/20/klotho-hope-for-increased-longevity-and-reduced-neurodegenerative-disease-part-1/

Will Klotho Prevent or Slow Dementia?

Klotho: Hope For Increased Longevity And Reduced Neurodegenerative Disease

“Renewed interest in a protein called klotho is pervading the scientific world. Klotho is a known anti-inflammatory protein that also contains anti-aging properties. In this two-part series, we will explore what klotho is, how it might impact inflammatory brain diseases, and how it ultimately prevents aging.”

#alzheimers #dementia #longevity #klotho #lecanemab #donanemab #aging
https://www.forbes.com/sites/williamhaseltine/2023/02/20/klotho-hope-for-increased-longevity-and-reduced-neurodegenerative-disease-part-1/

Will Klotho Prevent or Slow Dementia?

Klotho: Hope For Increased Longevity And Reduced Neurodegenerative Disease

“Renewed interest in a protein called klotho is pervading the scientific world. Klotho is a known anti-inflammatory protein that also contains anti-aging properties. In this two-part series, we will explore what klotho is, how it might impact inflammatory brain diseases, and how it ultimately prevents aging.”

#alzheimers #dementia #longevity #klotho #lecanemab #donanemab #aging
https://www.forbes.com/sites/williamhaseltine/2023/02/20/klotho-hope-for-increased-longevity-and-reduced-neurodegenerative-disease-part-1/

Will Klotho Prevent or Slow Dementia?

Klotho: Hope For Increased Longevity And Reduced Neurodegenerative Disease

“Renewed interest in a protein called klotho is pervading the scientific world. Klotho is a known anti-inflammatory protein that also contains anti-aging properties. In this two-part series, we will explore what klotho is, how it might impact inflammatory brain diseases, and how it ultimately prevents aging.”

#alzheimers #dementia #longevity #klotho #lecanemab #donanemab #aging
https://www.forbes.com/sites/williamhaseltine/2023/02/20/klotho-hope-for-increased-longevity-and-reduced-neurodegenerative-disease-part-1/

Do we have #Alzheimer’s disease all wrong?

“As Science noted in its story on the retracted paper, scientists are still debating whether the #amyloid theory is viable. The skeptics cite the fraudulent research and lack of a genuine breakthrough; supporters can point to this new class of drugs including #donanemab that have led to some improvement in some patients.”

https://www.vox.com/future-perfect/355108/alzheimers-disease-drug-approval-research-retraction

Two Is Better Than One in the Alzheimer’s Market

“Last week, a panel of independent advisers to the FDA unanimously voted in support of Eli Lilly’s #donanemab, a competitor in the same class of drugs that target #amyloid plaques in the brain. The #FDA is expected to decide on whether to approve the drug by the end of the year.

Life expectancies around the world have surged in recent decades, increasingly putting people at risk of #dementia. About one in nine seniors has #Alzheimer’s disease, the most common cause of the condition, which works out to some seven million Americans.”

https://finance.yahoo.com/news/two-better-one-alzheimer-market-110000384.html

#Alzheimer’s drug with modest benefits wins backing of #FDA advisers

"...The committee convened to evaluate donanemab said that more #research is still needed on the #drug ..."

#Dementia #Alzheimers #Donanemab #Neurology #Care #Health #MedMastodon

https://www.nature.com/articles/d41586-024-01726-w?utm_medium=Social&utm_campaign=nature&utm_source=Twitter#Echobox=1718102905

#Dementia
'#Alzheimer’s ‘breakthrough’ stalls: why a much-hyped drug is facing approval delays

The benefits of drugs such as #donanemab, £aducanumab and #lecanemab are proving harder to quantify than potential harms, experts say'
https://www.theguardian.com/society/2024/mar/24/alzheimers-breakthrough-drugs-medicine-donanemab-aducanumab-lecanemab
#Health

Alzheimer’s breakthrough as blood tests could be offered on NHS | The Independent
https://www.independent.co.uk/news/health/alzheimers-blood-tests-nhs-cure-b2444022.html

#Alzheimers
#AlzheimersDiagnosis
#Dementia
#BloodTest
#NHS
#BloodBiomarkerChallenge
#AlzheimersResearchUK
#AlzheimersSociety
#NationalInstituteForHealthAndCareResearch
#Rochester
#EliLilly
#HongKong
#US
#Donanemab
#Lecanemab
#DementiaTreatments

Expect a lot more promotion of #Alzheimer’s now that there is money to be made.

Just wished the new drugs worked and there were not so many side effects 🤯

“Timely detection and diagnosis of AD are important because they may enable earlier initiation of informed disease management, earlier opportunities to support cognitive well-being, and earlier consideration of therapeutic options”

#Lecanamab #Donanemab
https://www.timehidesalz.com

Expect a lot more promotion of #Alzheimer’s now that there is money to be made.

Just wished the new drugs worked and there were not so many side effects 🤯

“Timely detection and diagnosis of AD are important because they may enable earlier initiation of informed disease management, earlier opportunities to support cognitive well-being, and earlier consideration of therapeutic options”

#Lecanamab #Donanemab
https://www.timehidesalz.com

Expect a lot more promotion of #Alzheimer’s now that there is money to be made.

Just wished the new drugs worked and there were not so many side effects 🤯

“Timely detection and diagnosis of AD are important because they may enable earlier initiation of informed disease management, earlier opportunities to support cognitive well-being, and earlier consideration of therapeutic options”

#Lecanamab #Donanemab
https://www.timehidesalz.com

Expect a lot more promotion of #Alzheimer’s now that there is money to be made.

Just wished the new drugs worked and there were not so many side effects 🤯

“Timely detection and diagnosis of AD are important because they may enable earlier initiation of informed disease management, earlier opportunities to support cognitive well-being, and earlier consideration of therapeutic options”

#Lecanamab #Donanemab
https://www.timehidesalz.com

Expect a lot more promotion of #Alzheimer’s now that there is money to be made.

Just wished the new drugs worked and there were not so many side effects 🤯

“Timely detection and diagnosis of AD are important because they may enable earlier initiation of informed disease management, earlier opportunities to support cognitive well-being, and earlier consideration of therapeutic options”

#Lecanamab #Donanemab
https://www.timehidesalz.com

Können neue #Medikamente die #Demenz besiegen?
Therapeutische #Antikörper, die sich gegen #Proteinablagerungen im #Gehirn von Menschen mit #Alzheimer richten, stehen in #Europa kurz vor der Zulassung. Bei wie vielen Betroffenen ihre positiven Effekte die Nachteile der Behandlung aufwiegen, ist noch unklar.

Zwei neue Wirkstoffe – #Lecanemab und #Donanemab – sollen #Alzheimerpatienten vor geistigem Abbau schützen.

(...)

https://www.spektrum.de/news/alzheimer-wie-wirksam-sind-lecanemab-und-donanemab/2184111 #Wissenschaft #Medizin

Können neue #Medikamente die #Demenz besiegen?
Therapeutische #Antikörper, die sich gegen #Proteinablagerungen im #Gehirn von Menschen mit #Alzheimer richten, stehen in #Europa kurz vor der Zulassung. Bei wie vielen Betroffenen ihre positiven Effekte die Nachteile der Behandlung aufwiegen, ist noch unklar.

Zwei neue Wirkstoffe – #Lecanemab und #Donanemab – sollen #Alzheimerpatienten vor geistigem Abbau schützen.

(...)

https://www.spektrum.de/news/alzheimer-wie-wirksam-sind-lecanemab-und-donanemab/2184111 #Wissenschaft #Medizin

Können neue #Medikamente die #Demenz besiegen?
Therapeutische #Antikörper, die sich gegen #Proteinablagerungen im #Gehirn von Menschen mit #Alzheimer richten, stehen in #Europa kurz vor der Zulassung. Bei wie vielen Betroffenen ihre positiven Effekte die Nachteile der Behandlung aufwiegen, ist noch unklar.

Zwei neue Wirkstoffe – #Lecanemab und #Donanemab – sollen #Alzheimerpatienten vor geistigem Abbau schützen.

(...)

https://www.spektrum.de/news/alzheimer-wie-wirksam-sind-lecanemab-und-donanemab/2184111 #Wissenschaft #Medizin

Können neue #Medikamente die #Demenz besiegen?
Therapeutische #Antikörper, die sich gegen #Proteinablagerungen im #Gehirn von Menschen mit #Alzheimer richten, stehen in #Europa kurz vor der Zulassung. Bei wie vielen Betroffenen ihre positiven Effekte die Nachteile der Behandlung aufwiegen, ist noch unklar.

Zwei neue Wirkstoffe – #Lecanemab und #Donanemab – sollen #Alzheimerpatienten vor geistigem Abbau schützen.

(...)

https://www.spektrum.de/news/alzheimer-wie-wirksam-sind-lecanemab-und-donanemab/2184111 #Wissenschaft #Medizin

Können neue #Medikamente die #Demenz besiegen?
Therapeutische #Antikörper, die sich gegen #Proteinablagerungen im #Gehirn von Menschen mit #Alzheimer richten, stehen in #Europa kurz vor der Zulassung. Bei wie vielen Betroffenen ihre positiven Effekte die Nachteile der Behandlung aufwiegen, ist noch unklar.

Zwei neue Wirkstoffe – #Lecanemab und #Donanemab – sollen #Alzheimerpatienten vor geistigem Abbau schützen.

(...)

https://www.spektrum.de/news/alzheimer-wie-wirksam-sind-lecanemab-und-donanemab/2184111 #Wissenschaft #Medizin

Disease Modifying Therapy for #Alzheimer's #Dementia

"The long-awaited era of disease-modifying therapy for Alzheimer’s disease has finally arrived and will substantially impact how the disease is perceived and managed. The drugs closest to widespread clinical implementation are #lecanemab and #donanemab—intravenous #MonoclonalAntibodies that remove β #amyloid plaques from the #brain and can slow cognitive and functional decline."
#leqembi
https://cnmri.com/2023/07/21/disease-modifying-therapy-for-alzheimers/

Disease Modifying Therapy for #Alzheimer's #Dementia

"The long-awaited era of disease-modifying therapy for Alzheimer’s disease has finally arrived and will substantially impact how the disease is perceived and managed. The drugs closest to widespread clinical implementation are #lecanemab and #donanemab—intravenous #MonoclonalAntibodies that remove β #amyloid plaques from the #brain and can slow cognitive and functional decline."
#leqembi
https://cnmri.com/2023/07/21/disease-modifying-therapy-for-alzheimers/

Disease Modifying Therapy for #Alzheimer's #Dementia

"The long-awaited era of disease-modifying therapy for Alzheimer’s disease has finally arrived and will substantially impact how the disease is perceived and managed. The drugs closest to widespread clinical implementation are #lecanemab and #donanemab—intravenous #MonoclonalAntibodies that remove β #amyloid plaques from the #brain and can slow cognitive and functional decline."
#leqembi
https://cnmri.com/2023/07/21/disease-modifying-therapy-for-alzheimers/

Disease Modifying Therapy for #Alzheimer's #Dementia

"The long-awaited era of disease-modifying therapy for Alzheimer’s disease has finally arrived and will substantially impact how the disease is perceived and managed. The drugs closest to widespread clinical implementation are #lecanemab and #donanemab—intravenous #MonoclonalAntibodies that remove β #amyloid plaques from the #brain and can slow cognitive and functional decline."
#leqembi
https://cnmri.com/2023/07/21/disease-modifying-therapy-for-alzheimers/